Medicine
The GW School of Medicine and Health Sciences has been selected to serve as one of 24 participating sites for the Phase 2 clinical trial to evaluate additional COVID-19 booster shots in adults, including multiple vaccines based on viral variants such as Delta and Omicron. The trial aims to…
At the George Washington University School of Medicine and Health Sciences, women have been trailblazers, advancing medical education, transforming care, and, of course, breaking glass ceilings.
New Full-Service Hospital and Integrated Health Care System Is Scheduled to Open in 2024
George Washington University researchers have developed a blood test that quickly detects if someone has COVID-19 and predicts how severely the immune system will react to the infection, according to a new study coming out today in PLOS One. The findings could one day lead to a powerful tool to…
A $1 million gift from Ulvi M. and Reykhan Kasimov seeks to advance development of a new technique that uses RNA transcript levels to identify biomarkers in the blood stream, which can help detect active infections in the body.
Congratulations to Andrew Choi, MD ’08, on his award recognizing his leadership for the American College of Cardiology Mid-Atlantic Capital Cardiology Symposium.
In a recent study, Tim McCaffrey, PhD, professor of medicine at the George Washington University School of Medicine and Health Sciences, led a team of researchers conducting the largest RNA expression analysis of human coronary artery disease to date.
Kofi Essel, MD ’11, MPH ’17, assistant professor of medicine at the GW School of Medicine and Health Sciences (SMHS), and Nicole Farmer, MD, staff scientist with the National Institutes of Health (NIH) Clinical Center and an adjunct associate professor of medicine at SMHS, will bring their…
David Diemert, MD, clinical director of the GW Vaccine Research Unit and professor of medicine at the George Washington University School of Medicine and Health Sciences discusses what scientists know about the Delta variant.
A vaccine for Lassa fever may be on the horizon, thanks to a new clinical trial jointly led by Elissa Malkin, DO, MPH, assistant research professor of medicine at the George Washington University School of Medicine and Health Sciences.